about
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade dis...
Read More
13.10
-0.22
(-1.65%)
919.4K
XNAS Volume
XNAS 09 Dec, 2025 4:30 PM (EST)
Low Financial Strength
Expensive Valuation
Technically Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
Arvinas Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..